[BMJ] A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis |
|
This post will be closed automatically in 2026-11-01 03:02
Reward10points
|
post
reply
points
1320
10
A randomised, placebo-controlled study of RIPK1 inhibitor GSK2982772 in patients with active ulcerative colitis
10
Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification
10
Predictors of a successful glucocorticoid tapering and withdrawal in an inception cohort of patients with lupus nephritis and associations with long-term outcomes and damage accrual
10
Beyond borders: cystic fibrosis survival between Australia, Canada, France and New Zealand
10
Assessing the relationship between hypospadias risk and parental occupational exposure to potential endocrine-disrupting chemicals
